- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03721224
Psychiatric Disorders in Children With Psychogenic Cough
July 18, 2019 updated by: Abdurrahman Cahid Örengül, Bezmialem Vakif University
Psychiatric Disorders and Clinical Features of Children With Psychogenic Cough
The study aims to evaluate psychiatric disorders and clinical features of children with psychogenic cough.
Psychiatric disorders are assessed via a semi-structured interview (Kiddie Schedule for Affective Disorders and Schizophrenia) and clinical features are investigated via sociodemographic form, which was developped by researchers.
Investigator planned to compare psychiatric diagnoses, specifically anxiety and depression, with children referred to pediatric clinics.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
94
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Fatih
-
Istanbul, Fatih, Turkey
- Bezmialem Vakif University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 years to 18 years (ADULT, CHILD)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients who were diagnosed as having psychogenic cough between 2015 and 2018 years.
Age and gender matched control who don't have any chronical health problems.
Description
Inclusion Criteria:
- Having psychogenic cough for study group.
- Referred to pediatric clinics.
Exclusion Criteria:
- Chronical psychiatric disorder and pediatric disease history for control group.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Children with psychogenic cough
children who were examined by Pediatric Respiratory Disease specialist and diagnosed as having a psychogenic cough.
|
Both of the clinical and control group will be evaluated via Psychiatric semi-structured interview
|
|
control subjects
children who were referred to pediatrics clinics and do not have a chronical disease.
|
Both of the clinical and control group will be evaluated via Psychiatric semi-structured interview
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Psychiatric disorders
Time Frame: Baseline
|
Total rate of psychiatric disorders, specifically internalizing disorders, identified via semi-structured diagnostic interview
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Abdurrahman Cahid Orengul, Bezmialem University Department of Child and Adolescent Psychiatry
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
September 1, 2018
Primary Completion (ACTUAL)
December 1, 2018
Study Completion (ACTUAL)
January 1, 2019
Study Registration Dates
First Submitted
October 22, 2018
First Submitted That Met QC Criteria
October 24, 2018
First Posted (ACTUAL)
October 26, 2018
Study Record Updates
Last Update Posted (ACTUAL)
July 19, 2019
Last Update Submitted That Met QC Criteria
July 18, 2019
Last Verified
July 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- BVU Psychogenic cough study 1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.